Return to study ST002767 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid ME716855 14-HDoHE 11.70-Reversed phase NEGATIVE ION MODE
16(17)-epoxy-4,7,10,13,19-docosapentaenoic acid ME716875 16(17)-EpDPE 13.04-Reversed phase NEGATIVE ION MODE
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid ME716854 17-HDoHE 11.39-Reversed phase NEGATIVE ION MODE
18-(3-ethyloxiran-2-yl)octadeca-4,7,10,13,16-penta... ME716874 19(20)-EpDPE 12.65-Reversed phase NEGATIVE ION MODE
19,20-dihydroxydocosa-4,7,10,13,16-pentaenoic acid ME716835 19,20-DiHDPE 8.66-Reversed phase NEGATIVE ION MODE
4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid ME716856 4-HDoHE 13.02-Reversed phase NEGATIVE ION MODE
Resolvin D1 ME716822 Resolvin D1 5.37-Reversed phase NEGATIVE ION MODE


  logo